Public shareholders via NASDAQ
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$6.0B
Focus Areas
5
Top Stage
Commercial
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Rhythm Pharmaceuticals | $6.0B |
| Nymox Pharmaceutical | $18.3M |